|
|
The Latin America Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Hilton Hotel, Buenos Aires, Argentina, March 11-14, 2010 |
|
| |
| Saturday, March 13, 2010 |
 |
|
|
HALL A |
|
08:30-10:30 |
Session 13
T2D-FIRST LINE OF THERAPY?
Chairpersons: M. García de los Rios, Chile B. Itzhak, Israel |
|
|
Combination of two agents
Combination therapy: S. Del Prato, Italy
Monotherapy: P. Home, UK
Secretagogues; Which one?
M.V. Vinocour Fornieri, Costa Rica
PANEL DISCUSSION
C. Belzarena, Uruguay M. García de los Rios, Chile C. Musso, Argentina
|
|
|
Session 14
GLUCACON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND DIPEPTYDIL PEPTIDASE-4 (DPP-4) INHIBITORS. A CLINICAL COMPARISON
Chairperson: H.C. Pedrosa, Brazil |
|
Glycaemic control
S. Kahn, USA
Impact on non glycaemic effect
J. Rosas Guzmán, Mexico
Potential to reduce CV risk
R.D. Santos, Brazil
PANEL DISCUSSION
P. Arias, Argentina F. Lavalle, Mexico R. Lyra, Brazil C. Zubiate-Lopez, Peru
|
|
13:30-14:20 |
GUIDED POSTER TOUR #2
Poster Presentation Area |
| |
|
|
13:30-14:20 |
Session 15
MEET THE PROFESSOR |
|
Post meal glucose variability: Does it make a difference in prediabetes or diabetes?
Coordinator: M. Escalante, Mexico
Professor: J. Tuomilehto, Finland |
|
14:20-16:00
|
Session 16
TREATMENT TARGET: SHOULD WE TARGET ON BETA CELL ONLY?
Chairperson: J. Mestman, Argentina |
|
Beta cell
J.J. Gagliardino, Argentina
Alpha cell, muscle, liver and episode tissue
R.A. DeFronzo, USA
PANEL DISCUSSION
P. Acshner, Colombia J. Rosas Guzmán, Mexico M.A. Tambascia, Brazil
|
|
16:30-18:00 |
Session 17
DIABETIC FOOT: INTERDISCIPLINARY INTERVENTION
Chairperson: H.C. Pedrosa, Brazil |
|
Vascular surgeon
A.C. de Souza, Brazil
Orthopaedic intervention
M. Carrasco, Argentina
Cost of the diabetic foot
A. Odriozola, Spain
PANEL DISCUSSION
M. Carrasco, Argentina A.C. de Souza, Brazil M. Escalante, Colombia H.C. Pedrosa, Brazil
|
|
HALL B |
|
08:30-10:30 |
Session 18
OBESITY AND METABOLIC SYNDROME
Chairperson: S. Kahn, USA M. Katz, Argentina |
|
Diet, exercise or both?
Diet: D. Marrero, USA
Excercise: M. Rodríguez, Argentina
Is there light in the future for new pharmalogical agents?
S. Klein, USA
Structural and functional disorders of the thyroid and their relationship to diabetes, obesity, and insulin resistance
J. Garber, USA
|
|
11:00-12:30
|
Session 19
LIPIDS IN DIABETES
Chairperson: C. Rondinone, USA |
|
Metabolic consequences of lipotoxicity in obesity: Prevention and treatment
K. Cusi, USA
The expandability hypothesis and diabetes: What does it have to do with liver, muscle and pancreatic fat?
A.Godoy-Matos, Brazil
Prevention of T2DM: To treat or not to treat?
Treat: A. Halpern, Brazil
Do not treat: K. Cusi, USA
|
|
|
Session 20
MEET THE PROFESSOR |
|
|
Nonalcoholic fatty liver disease (NAFLD): Fact or fiction?
Coordinator: I. Raz, Israel
Professor: K. Cusi, USA
|
|
14:20-16:00
|
Session 21
TREATMENTS OF T2D
Chairperson: S. Gutt, Argentina |
|
Bariatric surgery as a treatment for diabetes and obesity
Pro: A. Halpern, Brazil
Con: S. Klein, USA
PANEL DISCUSSION
A. Chacra, Brazil A.Godoy-Matos, Brazil M. Katz, USA S. Schraier, Argentina
|
| 16:30-18:00 |
Session 22
SMOKING CESSATION - GET READY FOR SUCCESS!
Chairperson: P.M. Nilsson, Sweden |
|
Evolutionary perspectives on addiction leading to smoking, obesity and drug abuse
P.M. Nilsson, Sweden
Smoking. Global epidemic smoking cessation strategies. The evidence
V. Schoj, Argentina
Non-pharmacological support and counselling
P. Tønnesen, Finland
Drug treatment
P.M. Nilsson, Sweden
PANEL DISCUSSION
P.M. Nilsson, Sweden V. Schoj, Argentina P. Tønnesen, Finland
|
|
HALL C |
|
8:30-10:30 |
Session 23
NEW HORIZONS IN THE TREATMENT OF T2D
Chairpersons: O. Minuchin, Israel C. Zubiate-Lopez, Peru |
|
Early insulin therapy in T2D patients
Pro: A. Chacra, Brazil
Con: L.E. Litwak, Argentina
Thiazolidinedione (TZD) dead or alive?
Pro: I. Sinay, Argentina
Con: P. Aschner, Colombia
PANEL DISCUSSION
A. Chacra, Brazil D. Marante, Venezuela M.V. Vinocour Fornieri, Costa Rica
|
|
11:00-12:30 |
Session 24
NOVEL TREATMENTS IN DIABETIC PATIENTS WITH HYPERTENSION
Chairperson: M.V. Vinocour Fornieri, Costa Rica |
|
Antihypertensive treatment in “normotensive diabetic patient”
Pro: M. Bendersky, Argentina
Con: A. Ramírez, Argentina
The positive side of future treatments
D. Marante, Venezuela
PANEL DISCUSSION
M. Bendersky, Argentina D. Marante, Venezuela A. Ramírez, Argentina M.V. Vinocour Fornieri, Costa Rica
|
|
13:30-14:20 |
Session 25
MEET THE PROFESSOR
Chairperson: J.F. Navarro-González, Spain |
|
The use of diurectics in the treatments of blood pressure in patients with T2D
Pro: P.M. Nilsson, Finland
Con: L. Raij, USA
|
|
14:20-16:00 |
Session 26
DIABETIC NEPHROPATHY BEYOND RAS INHIBITOR
Chairperson: J. Garber, USA |
|
Calcium channel blockers/ diuretics
L. Raij, USA
Double or triple RAS blocked
F. Lavalle, Argentina
Blockade of inflammatory pathways
J.F. Navarro-González, Spain
PANEL DISCUSSION
J. Garber, USA R. Lyra, Brazil J.F. Navarro-Gonzalez, Spain A. Villamil, Argentina
|
|
16:30-18:00 |
Session 27
TREATMENT GOALS IN DIABETES
Chairperson: M.A. Tambascia, Spain |
|
Near normal HbA1c in T2DM?
Pro: S. Del Prato, Italy
Con: J. Davidson, USA
How low is low in blood pressure control in patients with diabetes?
R. Carmena, Spain
PANEL DISCUSSION
R. Carmena, Spain S. Del Prato, Italy M.A. Tambascia, Brazil
|
|
|
|
|
English
Español
WebStudio.co.il